3Estevev AG, Stutzmanm J M,Barbeito L. Protetctive effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron enriched cultures[J]. Eur J Pharmacol, 1995,280(1) :47- 53.
4Umemiya M, Berger AJ. Inhibition by riluzole of glycinergic postsynaptic currents in rat hypoglossal motoneurones[J]. Br J Pharmacol, 1995,116:3327 - 3330.
5Bryson HM, Fulton BP. Riluzole: a review of its pharmacodynamic and pharmcokinetic properties and therapeutic potential in amyotrophic lateral sclerosis[ J ]. Drugs, 1996,52:549 - 563.
6Bruno R, Vivier N, Montay G, et al. Population pharmacokineics of riluzole in patients with amyotrophic lateral sclerosis[J]. Clin Pharmacol Ther, 1997,62 (5): 518 - 526.
7Hugon J. Riluzole and ALS therapy[ J ]. Wein Med Wochensohr, 1996,146:185 - 187.
8Lacomblez L, Bensimon G, Leigh PN, et al: Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis/Riluzole study group Ⅱ [see comments] [J].Lancet, 1996,347:1425 - 1431.
9Meininger V, Dib M,Aubin F, et al. The riluzole early access programme: descriptive analysis of 844 patients in france,ALS/Riluzole study group Ⅲ [J] . J Neurol, 1999,244(Suppl 2) :22 - 25.
10Yanagisawa N,Shndo M. Neuroprotective therapy for amyotrophic lateral sclerosis[ J ]. Rinsho Shinkeigaku, 1999,36:1329 - 1330.
4Januschowski K, Mtiller S, Krupp C, Spitzer MS, Hurst J, Schul- theiss M, et al. Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retinae [J ]. J V/s Exp ,2015,22:97.
5WSffer J,Gorji A, Speckmann E J, Wassmann H. Interstitial ami- no acid concentrations in rodent brain tissue during chemical is-chemia [J]. JNeurosci Res,2014,92(8) :955-963.
6Zheng S, Yang H, Chen Z, Zheng C, Lei C, Lei B. Activation of liver X receptor protects inner retinal damage induced by N- methyl-D-aspaxmte [ J]. Invest Ophthalmol Vis Sci,2015,56 (2) : 1168-1180.
7Haidet-Phillips AM, Maragakis NJ. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis(ALS) [ J ]. Brain Res, 2015, [ Epub ahead of print ].
8Carbone M,Duty S,Rattray M. Riluzole elevates GLT-1 activity and levels in striatal astrocytes [ J ]. Neurochem Int, 2012,60 (1) :31-38.
9Yohay K,Tyler B, Weaver KD, Pardo AC, Gineel D, Blakeley J, et a/. Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models: Laboratory investigation [ J ]. J Neurosurg, 2014, 120 (4) :854-863.
10Htmsberger HC, Weitzner DS, Rudy CC, Hiekman Jig, IAbeli EM, Speer RR,et al. Riinzole rescues glutamate alterations,cognitive deficits, and tau pathology associated with P301L tau expression [ J ]. J Neurochem,2015, [ Epub ahead of print .
